Concepedia

Diana Beyer

DB

5

Publications

408

Citations

5

H-Index

2007

Active since

Affiliations

Noxxon Pharma (Germany)(Current)

Diana Beyer is an author at Noxxon Pharma (Germany) specializing in drug development, small molecules, and drug discovery.

Top concepts

Publications per year

2007–2021

5

Publications

5

C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria

Jan Menne, Dirk Eulberg, Diana Beyer et al. · Nephrology Dialysis Transplantation · 2016 · 192 citations · Full text

Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia

Michael Steurer, Marco Montillo, Lydia Scarfò et al. · Haematologica · 2019 · 85 citations · Full text

Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects

Meggy Suarez‐Carmona, Anja Williams, Jutta Schreiber et al. · Journal for ImmunoTherapy of Cancer · 2021 · 69 citations · Full text

Rational Design of Novel, Potent Small Molecule Pan-Selectin Antagonists

Remo Kranich, Anke S. Busemann, Daniel Bock et al. · Journal of Medicinal Chemistry · 2007 · 46 citations · Full text

, , +16

EFFECTS OF THE PAN-SELECTIN ANTAGONIST BIMOSIAMOSE (TBC1269) IN EXPERIMENTAL HUMAN ENDOTOXEMIA

Florian Mayr, Christa Firbas, Judith Leitner et al. · Shock · 2008 · 16 citations

Rows per page

1–5 of 5